Effects of Lutein Supplementation on Oxidative Stress and Inflammation in Healthy Nonsmokers
Sponsor: Peking University
A PHASE1/PHASE2 clinical study on Oxidative Stress in Healthy Subjects, this trial is ongoing. The trial is conducted by Peking University and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1/PHASE2
-
Feb 2025 — Sep 2025 [monthly]
Unknown PHASE1/PHASE2
-
Sep 2024 — Feb 2025 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Sep 2020 [monthly]
Unknown Status PHASE1_PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE1_PHASE2
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University
- Xi'an Jiaotong University
For direct contact, visit the study record on ClinicalTrials.gov .